Found: 142
Select item for more details and to access through your institution.
Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3736, doi. 10.1111/dom.15268
- By:
- Publication type:
- Article
Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3478, doi. 10.1111/dom.15240
- By:
- Publication type:
- Article
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3347, doi. 10.1111/dom.15234
- By:
- Publication type:
- Article
Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2910, doi. 10.1111/dom.15186
- By:
- Publication type:
- Article
Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: Results from a retrospective cohort study using a Canadian private payer claims database.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1704, doi. 10.1111/dom.15025
- By:
- Publication type:
- Article
Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross‐sectional survey.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1408, doi. 10.1111/dom.14973
- By:
- Publication type:
- Article
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1998, doi. 10.1111/dom.14787
- By:
- Publication type:
- Article
Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1926, doi. 10.1111/dom.14421
- By:
- Publication type:
- Article
The importance of the initial period of basal insulin titration in people with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 722, doi. 10.1111/dom.13946
- By:
- Publication type:
- Article
Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1529, doi. 10.1111/dom.13732
- By:
- Publication type:
- Article
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 858, doi. 10.1111/dom.12892
- By:
- Publication type:
- Article
Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40287-w
- By:
- Publication type:
- Article
Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US).
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 8, p. 1299, doi. 10.1007/s13300-023-01423-3
- By:
- Publication type:
- Article
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 913, doi. 10.1007/s13300-022-01247-7
- By:
- Publication type:
- Article
Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1689, doi. 10.1007/s13300-021-01063-5
- By:
- Publication type:
- Article
Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study).
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 6, p. 2305, doi. 10.1007/s13300-019-00687-y
- By:
- Publication type:
- Article
Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 925, doi. 10.2147/PPA.S46805
- By:
- Publication type:
- Article
Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Relationship of the metabolic syndrome to carotid ultrasound traits.
- Published in:
- Cardiovascular Ultrasound, 2006, v. 4, p. 28, doi. 10.1186/1476-7120-4-28
- By:
- Publication type:
- Article
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes.
- Published in:
- Cardiovascular Ultrasound, 2005, v. 3, p. 15, doi. 10.1186/1476-7120-3-15
- By:
- Publication type:
- Article
Exploring quality improvement for diabetes care in First Nations communities in Canada: a multiple case study.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09442-3
- By:
- Publication type:
- Article
Case study of evaluations that go beyond clinical outcomes to assess quality improvement diabetes programmes using the Diabetes Evaluation Framework for Innovative National Evaluations ( DEFINE).
- Published in:
- Journal of Evaluation in Clinical Practice, 2016, v. 22, n. 5, p. 644, doi. 10.1111/jep.12510
- By:
- Publication type:
- Article
The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree.
- Published in:
- Journal of Human Genetics, 1999, v. 44, n. 4, p. 225, doi. 10.1007/s100380050148
- By:
- Publication type:
- Article
Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.
- Published in:
- Journal of Human Genetics, 1999, v. 44, n. 1, p. 10, doi. 10.1007/s100380050097
- By:
- Publication type:
- Article
-6A Promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree.
- Published in:
- Journal of Human Genetics, 1998, v. 43, n. 1, p. 37, doi. 10.1007/s100380050034
- By:
- Publication type:
- Article
Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort.
- Published in:
- Diabetes, 2023, v. 72, n. 11, p. 1664, doi. 10.2337/db22-1050
- By:
- Publication type:
- Article
347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-347-P
- By:
- Publication type:
- Article
95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-95-LB
- By:
- Publication type:
- Article
677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-677-P
- By:
- Publication type:
- Article
956-P: Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-956-P
- By:
- Publication type:
- Article
385-P: Health-Care Providers' Emotional Responses to Their Patients' Hypoglycemic Events: The InHypo-DM Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-385-P
- By:
- Publication type:
- Article
2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2192-PUB
- By:
- Publication type:
- Article
985-P: Oral Semaglutide as Add-On to Insulin in T2D: PIONEER 8.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-985-P
- By:
- Publication type:
- Article
381-P: Real-World Evidence that Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-381-P
- By:
- Publication type:
- Article
2198-PUB: Real-World Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2198-PUB
- By:
- Publication type:
- Article
1098-P: Treatment Satisfaction with Gla-300, IDeg-100, and Gla-100 in Insulin-Naïve T2DM: The BRIGHT and EDITION 3 Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1098-P
- By:
- Publication type:
- Article
1095-P: Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1095-P
- By:
- Publication type:
- Article
Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Prospective Associations of Vitamin D With β-Cell Function and Glycemia.
- Published in:
- Diabetes, 2011, v. 60, n. 11, p. 2947, doi. 10.2337/db11-0465
- By:
- Publication type:
- Article
Controlled Trial of Quality Improvement of Cholesterol Management in Diabetes in Remote Aboriginal Communities.
- Published in:
- Diabetes, 2007, v. 56, p. A312
- By:
- Publication type:
- Article
Paraoxonase 1 Mass (PON1) and Microvascular Complications in Type 2 Diabetes (DM).
- Published in:
- Diabetes, 2007, v. 56, p. A213
- By:
- Publication type:
- Article
Limitations of hemoglobin A<sub>1c</sub> in the management of type 2 diabetes mellitus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Managing cardiometabolic risk in primary care.
- Published in:
- Canadian Family Physician / Médecin de Famille Canadien, 2012, v. 58, n. 4, p. 389
- By:
- Publication type:
- Article
Hypertension in people with type 2 diabetes: Update on pharmacologic management.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Hypertension in people with type 2 diabetes.
- Published in:
- Canadian Family Physician / Médecin de Famille Canadien, 2011, v. 57, n. 9, p. 997
- By:
- Publication type:
- Article
Clinical inertia in patients with T2DM requiring insulin in family practice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical inertia in patients with T2DM requiring insulin in family practice.
- Published in:
- Canadian Family Physician / Médecin de Famille Canadien, 2010, v. 56, n. 12, p. e418
- By:
- Publication type:
- Article
Implementing electronic health records: Key factors in primary care.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Implementing electronic health records.
- Published in:
- Canadian Family Physician / Médecin de Famille Canadien, 2008, v. 54, n. 5, p. 730
- By:
- Publication type:
- Article